Characterization of Postinfusion Phenotypic Differences in Fresh Versus Cryopreserved TCR Engineered Adoptive Cell Therapy Products.

J Immunother · 2018 · PMC5959255 · PMID 29470191

Europe PMC DOI

hedged sentence

0.0660

closest p · 1.3× alpha

0.0660

boldest claim

The sentences

nearly achieved significanceP =0.066so close (0.05 < p ≤ 0.1)

1 E), CCR7 elevation in shorter culture time nearly achieved significance (23.1% vs. 1.4%, P =0.066).

also in 9 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.